US MS star Tecfidera approved in Europe
This article was originally published in Scrip
Executive Summary
Biogen Idec's new multiple sclerosis drug Tecfidera (dimethyl fumarate) has been approved in Europe. The drug's first approval was in the US in March last year, and its launch continues to surpass expectations.